Home> Products> 36 hours

{ "products": [ { "_id": "68b6d6c76f14ecfa6add5d56", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SACUSMART 200", "description": "Description: \nSACUSMART 200 is a combination medicine containing Sacubitril (97 mg) and Valsartan (103 mg), specifically designed to manage chronic heart failure with reduced ejection fraction (HFrEF). This dual-acting therapy is classified as an angiotensin receptor neprilysin inhibitor (ARNI) and is widely prescribed to reduce the risk of cardiovascular death and hospitalization in patients with heart failure.\n\nHeart failure is a progressive condition where the heart cannot pump blood efficiently to meet the body’s needs. SACUSMART 200 improves the efficiency of the heart by relaxing blood vessels, reducing fluid retention, and lowering strain on the heart, helping patients live a better and longer life.\n\n \nWhat is SACUSMART 200?\n \n\nSACUSMART 200 is a highly effective heart failure medication that combines two active components:\n\nSacubitril (97 mg) – a neprilysin inhibitor that increases levels of natriuretic peptides, leading to vasodilation, sodium excretion, and reduced stress on the heart.\n\nValsartan (103 mg) – an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and prevents harmful effects of angiotensin II.\n\nTogether, these mechanisms make SACUSMART 200 a superior alternative to traditional ACE inhibitors or ARBs alone in treating chronic heart failure.\n\n \nUses of SACUSMART 200\n \n\nSACUSMART 200 is prescribed for:\n\nChronic heart failure with reduced ejection fraction (HFrEF)\n\nReducing risk of hospitalization due to worsening heart failure\n\nImproving survival rates in patients with heart failure\n\nEnhancing exercise tolerance and quality of life in long-term heart failure management\n\n \nBenefits of SACUSMART 200\n \n\nDual action with neprilysin inhibition + ARB effect for comprehensive heart protection\n\nProven to reduce mortality and hospitalization risk in heart failure patients\n\nImproves symptoms such as breathlessness, fatigue, and swelling\n\nHelps patients regain better physical stamina and daily activity levels\n\nLong-term use significantly contributes to improved quality of life\n\n \nPossible Side Effects of SACUSMART 200\n \n\nWhile SACUSMART 200 is effective and generally well tolerated, some patients may experience:\n\nLow blood pressure (hypotension)\n\nIncreased blood potassium levels (hyperkalemia)\n\nDizziness or light-headedness\n\nKidney function changes\n\nCough\n\nRarely, serious allergic reactions or angioedema (swelling of face, lips, or throat)\n\nImmediate medical attention is required if severe swelling, difficulty breathing, or fainting occurs.\n\n \nPrecautions Before Using SACUSMART 200\n \n\nDo not use if you are allergic to sacubitril, valsartan, or other ARBs\n\nAvoid if you have taken an ACE inhibitor within the last 36 hours due to the risk of angioedema\n\nNot recommended for patients with a history of hereditary angioedema\n\nCaution in patients with severe kidney or liver disease\n\nPregnant and breastfeeding women should avoid this medicine due to harmful effects on the baby\n\nAlways monitor blood pressure, kidney function, and potassium levels while on this treatment\n\n \nDrug Interactions\n \n\nSACUSMART 200 may interact with:\n\nACE inhibitors – should not be combined, risk of angioedema\n\nPotassium supplements or potassium-sparing diuretics – risk of high potassium\n\nNSAIDs (e.g., ibuprofen, naproxen) – may reduce kidney function\n\nLithium – risk of lithium toxicity\n\nDiuretics – may increase the risk of low blood pressure\n\nAlways inform your doctor about all medicines, supplements, or herbal products you are taking before starting SACUSMART 200.\n\n \nConclusion\n \n\nSACUSMART 200 (Sacubitril 97 mg & Valsartan 103 mg) is a breakthrough treatment in managing chronic heart failure with reduced ejection fraction (HFrEF). By combining neprilysin inhibition and angiotensin receptor blockade, it not only reduces symptoms but also significantly lowers the risk of hospitalization and death, improving both longevity and quality of life.\n\nFor patients living with heart failure, SACUSMART 200 offers a scientifically proven and clinically superior solution to regain control over their health and live a more fulfilling life.", "price": 750.0, "discountamount": 225.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2170, "imageuri": "https://productimages.withfloats.com/actual/68b6d6c9c4087f14f55d7d23.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b6d6c9c4087f14f55d7d23.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-02T11:36:39.17Z", "updatedon": "2025-09-02T11:36:39.17Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacusmart-200/2170", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril and Valsartan Tablets (97 mg + 103 mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c060caebebd090016591c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SUMOTROP NPX ", "description": "SUMOTROP NPX \nSumatriptan (85mg), Naproxen (500mg)\nIntroduction:\n\nSUMOTROP NPX combines Sumatriptan and Naproxen to offer powerful, dual-action relief for acute migraine attacks. Sumatriptan, a selective serotonin receptor agonist, and Naproxen, a nonsteroidal anti-inflammatory drug (NSAID), work together to alleviate migraine symptoms quickly and effectively, helping patients regain control of their lives.\nKey Features and Benefits:\n\nDual-Action Relief:\n\nSumatriptan (85mg): Targets serotonin (5-HT1) receptors to constrict dilated blood vessels in the brain, reducing headache pain and associated symptoms like nausea and sensitivity to light and sound.\nNaproxen (500mg): Reduces inflammation and pain through its action as an NSAID, providing additional relief and prolonging the effect of Sumatriptan.\nRapid and Long-Lasting Relief:\n\nThe combination of Sumatriptan and Naproxen ensures rapid onset of action, relieving migraine symptoms quickly. The anti-inflammatory properties of Naproxen also help maintain pain relief for a longer duration.\nComprehensive Symptom Management:\n\nSUMOTROP NPX addresses multiple migraine symptoms, including headache pain, nausea, and sensitivity to light and sound, providing comprehensive symptom relief.\nImproved Quality of Life:\n\nBy effectively managing migraine attacks, SUMOTROP NPX enables patients to resume their daily activities with minimal disruption, enhancing overall quality of life.\nWell-Tolerated and Safe:\n\nThis combination medication is generally well-tolerated, offering a favorable safety profile for patients needing acute migraine treatment.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended dose of SUMOTROP NPX is one tablet containing Sumatriptan (85mg) and Naproxen (500mg) taken orally at the first sign of a migraine attack.\nMaximum Dosage:\n\nDo not exceed two tablets in a 24-hour period. If the migraine returns after initial relief, a second dose may be taken at least 2 hours after the first dose.\nAdministration Instructions:\n\nSwallow the tablet whole with water. Taking the medication with food may help reduce gastrointestinal side effects associated with Naproxen.\nContinued Monitoring:\n\nRegular monitoring of migraine frequency, severity, and response to treatment is essential to optimize therapy and ensure patient safety.For further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/sumotrop-npx-133632", "price": 104.95, "discountamount": 31.48, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "85mg", "food", "Life", "Order", "lives", "EMAIL", "NSAID", "light", "sound", "water", "brain", "500mg", "nausea", "control", "product", "therapy", "severity", "response", "patients", "Naproxen", "Benefits", "first dose", "first sign", "one tablet", "rapid onset", "sensitivity", "two tablets", "information", "Sumatriptan", "second dose", "pain relief", "inflammation", "Introduction", "sterispharma", "SUMOTROP NPX", "sterisonline", "Key Features", "headache pain", "CALL/WHATSAPP", "Maximum Dosage", "Initial Dosage", "initial relief", "24-hour period", "patient safety", "longer duration", "overall quality", "Improved Quality", "daily activities", "additional relief", "migraine frequency", "Regular monitoring", "minimal disruption", "associated symptoms", "Long-Lasting Relief", "Continued Monitoring", "dilated blood vessels", "acute migraine attacks", "combination medication", "favorable safety profile", "acute migraine treatment", "multiple migraine symptoms", "Administration Instructions", "serotonin (5-HT1) receptors", "anti-inflammatory properties", "powerful, dual-action relief", "comprehensive symptom relief", "gastrointestinal side effects", "Comprehensive Symptom Management", "nonsteroidal anti-inflammatory drug", "selective serotonin receptor agonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1901, "imageuri": "https://productimages.withfloats.com/actual/666c060f492d7ea0aba1c9f3.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c060f492d7ea0aba1c9f3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T08:57:48.703Z", "updatedon": "2024-06-29T12:24:01.982Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sumotrop-npx-/1901", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SUMOTROP NPX ", "category": "NEUROLOGY RANGE", "tags": [ "sumatriptan injection buy", "Naproxen (500mg)", "Sumatriptan (85mg)", "Sumatriptan (85mg),", "sumotrop npx uses in hindi", "sumotrop npx price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c03124cb45413344ec7be", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SUMATROPH 50 ", "description": "SUMATROPH 50 \nSumatriptan succinate Rapid- Release (50mg)\nIntroduction:\n\nSUMATROPH 50 contains Sumatriptan succinate, a selective serotonin receptor agonist (triptan) used for the acute treatment of migraine attacks. With a dosage strength of 50mg in a rapid-release formulation, SUMATROPH 50 offers quick and effective relief from the debilitating symptoms of migraines, helping patients regain control over their daily lives.\nKey Features and Benefits:\n\nRapid-Release Formulation:\n\nSUMATROPH 50 is designed to provide rapid relief from migraine symptoms. Its quick absorption and onset of action help alleviate headache pain, nausea, and sensitivity to light and sound within a short period.\nTargeted Action:\n\nSumatriptan succinate specifically targets serotonin (5-HT1) receptors in the brain, leading to the constriction of dilated blood vessels, which is believed to be a primary cause of migraine pain. This targeted action effectively reduces the intensity and duration of migraine attacks.\nSymptom Relief:\n\nSUMATROPH 50 not only alleviates headache pain but also helps relieve associated migraine symptoms such as nausea, vomiting, and photophobia (sensitivity to light) or phonophobia (sensitivity to sound), providing comprehensive symptom relief.\nImproved Quality of Life:\n\nBy providing quick and effective relief from migraines, SUMATROPH 50 enables patients to resume their daily activities with minimal disruption, enhancing their overall quality of life.\nWell-Tolerated and Safe:\n\nSumatriptan is generally well-tolerated, with a favorable safety profile, making SUMATROPH 50 a reliable option for the acute treatment of migraines.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended dose of SUMATROPH 50 for adults is 50mg taken orally at the first sign of a migraine attack. The dose may be increased to 100mg if needed, based on individual response and tolerability.\nMaximum Dosage:\n\nDo not exceed 200mg in a 24-hour period. If the migraine returns after initial relief, a second dose may be taken at least 2 hours after the first dose.\nAdministration Instructions:\n\nSwallow SUMATROPH 50 tablets whole with water. The rapid-release formulation ensures quick absorption and onset of action.\nContinued Monitoring:\n\nRegular monitoring of migraine frequency, severity, and response to treatment is essential to optimize therapy and ensure patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/sumatroph-50-133683", "price": 148.4, "discountamount": 44.52, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Life", "50mg", "light", "100mg", "onset", "sound", "brain", "200mg", "Order", "water", "EMAIL", "adults", "nausea", "option", "therapy", "control", "duration", "severity", "patients", "vomiting", "Benefits", "intensity", "migraines", "first sign", "first dose", "sensitivity", "second dose", "photophobia", "daily lives", "phonophobia", "information", "constriction", "Introduction", "sterisonline", "tolerability", "Key Features", "short period", "rapid relief", "sterispharma", "primary cause", "headache pain", "CALL/WHATSAPP", "migraine pain", "patient safety", "24-hour period", "Initial Dosage", "Maximum Dosage", "initial relief", "acute treatment", "dosage strength", "Targeted Action", "overall quality", "effective relief", "quick absorption", "Improved Quality", "daily activities", "migraine attacks", "minimal disruption", "Regular monitoring", "migraine frequency", "individual response", "Continued Monitoring", "debilitating symptoms", "dilated blood vessels", "favorable safety profile", "rapid-release formulation", "serotonin (5-HT1) receptors", "Administration Instructions", "Swallow SUMATROPH 50 tablets", "associated migraine symptoms", "comprehensive symptom relief", "Sumatriptan succinate Rapid- Release", "selective serotonin receptor agonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1900, "imageuri": "https://productimages.withfloats.com/actual/666c03182d43284d72746dc6.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c03182d43284d72746dc6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T08:45:06.277Z", "updatedon": "2024-06-29T12:24:49.64Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sumatroph-50-/1900", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SUMATROPH 50 ", "category": "NEUROLOGY RANGE", "tags": [ "SUMATROPH 50", "", "sumatriptan 50 mg tablet uses", "Sumatriptan succinate Rapid- Release (50mg)", "sumatriptan side effects", "sumatriptan 50 mg tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be6b8aa93342004eef58f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 2 ", "description": "ROPINPRIME 2 \nRopinirole (2mg)\nIntroduction:\n\nRopinprime 2 is a medication containing Ropinirole, a potent dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 2mg, Ropinprime 2 is designed to effectively alleviate symptoms by mimicking dopamine's action in the brain, thus improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 2 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This action helps reduce motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 2 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 2 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 2mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 2 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 2 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 2 therapy to ensure therapeutic efficacy and patient safety.\n\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-2-133629", "price": 135.0, "discountamount": 40.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "RLS", "1mg", "8mg", "life", "aids", "food", "brain", "Order", "EMAIL", "0.5mg", "water", "0.25mg", "action", "nausea", "bedtime", "disease", "tremors", "patients", "Benefits", "condition", "Parkinson", "stiffness", "Ropinirole", "likelihood", "medication", "information", "Introduction", "bradykinesia", "independence", "tolerability", "initial dose", "sterisonline", "sterispharma", "greater ease", "Key Features", "CALL/WHATSAPP", "sleep quality", "starting dose", "motor symptoms", "patient safety", "multiple doses", "Initial Dosage", "overall comfort", "treatment plans", "slowed movement", "symptom control", "patient response", "symptom severity", "daily activities", "clinical response", "Maintenance doses", "Regular monitoring", "dopamine receptors", "uncontrollable urge", "2mg dosage strength", "Ropinprime 2 therapy", "healthcare providers", "therapeutic efficacy", "Continued Monitoring", "dopaminergic activity", "overall motor function", "potential side effects", "potent dopamine agonist", "Improved Motor Function", "uncomfortable sensations", "flexible dosing regimens", "individual patient needs", "Administration Instructions", "Swallow Ropinprime 2 tablets", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1895, "imageuri": "https://productimages.withfloats.com/actual/667d15dbce74849f89cdd68a.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d15dbce74849f89cdd68a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:44:08.261Z", "updatedon": "2024-06-27T07:33:46.566Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-2-/1895", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 2 ", "category": "NEUROLOGY RANGE", "tags": [ "Ropinirole (2mg)", "ROPINPRIME 2", "ropinirole side effects", "ropinirole side effects: weight gain", "ropinirole side effects in elderly" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be5a070774b1f84f699ad", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 1 ", "description": "ROPINPRIME 1 \nRopinirole (1mg)\nIntroduction:\n\nRopinprime 1 contains Ropinirole, a potent dopamine agonist used primarily to treat Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 1mg, Ropinprime 1 is designed to alleviate symptoms by mimicking the action of dopamine in the brain, thereby improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 1 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This mechanism helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 1 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 1 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 1mg dosage strength provides flexibility in dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 1 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 1 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 1 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/ropinprime-1-133628", "price": 124.0, "discountamount": 37.2, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "day", "8mg", "life", "food", "EMAIL", "water", "0.5mg", "Order", "brain", "nausea", "action", "0.25mg", "bedtime", "disease", "tremors", "patients", "Benefits", "movement", "mechanism", "condition", "Parkinson", "stiffness", "medication", "likelihood", "Ropinirole", "flexibility", "information", "bradykinesia", "independence", "tolerability", "Introduction", "sterisonline", "initial dose", "sterispharma", "Key Features", "greater ease", "CALL/WHATSAPP", "starting dose", "sleep quality", "motor symptoms", "Initial Dosage", "multiple doses", "patient safety", "symptom control", "treatment plans", "dosing regimens", "Flexible Dosing", "overall comfort", "symptom severity", "patient response", "daily activities", "Maintenance doses", "clinical response", "dopamine receptors", "Regular monitoring", "1mg dosage strength", "uncontrollable urge", "Continued Monitoring", "therapeutic efficacy", "healthcare providers", "Ropinprime 1 therapy", "dopaminergic activity", "overall motor function", "potential side effects", "potent dopamine agonist", "Improved Motor Function", "individual patient needs", "uncomfortable sensations", "Administration Instructions", "Swallow Ropinprime 1 tablets", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1894, "imageuri": "https://productimages.withfloats.com/actual/666be5a4475de163fe91643d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be5a4475de163fe91643d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:39:28.983Z", "updatedon": "2024-06-26T07:04:00.123Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-1-/1894", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 1 ", "category": "NEUROLOGY RANGE", "tags": [ "ROPINPRIME 1", "ropinirole side effects in elderly", "ropinirole side effects", "ropinirole warnings" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be4714cb45413344ec323", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 0.5 ", "description": "ROPINPRIME 0.5 \nRopinirole (0.5mg)\nIntroduction:\n\nRopinprime 0.5 contains Ropinirole, a dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 0.5mg, Ropinprime 0.5 aims to alleviate symptoms by mimicking the action of dopamine in the brain, thus improving motor function and enhancing quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 0.5 acts as a dopamine agonist, directly stimulating dopamine receptors in the brain. This action helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 0.5 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 0.5 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 0.5mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Ropinprime 0.5 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability.\nRestless Legs Syndrome:\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. Dosage may be adjusted according to patient response and symptom control.\nAdministration Instructions:\nSwallow Ropinprime 0.5 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 0.5 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-0-5-133627", "price": 60.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "aids", "life", "food", "Order", "water", "brain", "EMAIL", "0.25mg", "nausea", "action", "bedtime", "disease", "tremors", "patients", "Benefits", "stiffness", "condition", "Parkinson", "Ropinirole", "likelihood", "medication", "information", "Introduction", "initial dose", "independence", "greater ease", "tolerability", "Key Features", "sterispharma", "bradykinesia", "sterisonline", "CALL/WHATSAPP", "sleep quality", "starting dose", "patient safety", "motor symptoms", "Initial Dosage", "overall comfort", "treatment plans", "slowed movement", "symptom control", "dopamine agonist", "patient response", "daily activities", "symptom severity", "clinical response", "Regular monitoring", "dopamine receptors", "uncontrollable urge", "Continued Monitoring", "healthcare providers", "therapeutic efficacy", "0.5mg dosage strength", "dopaminergic activity", "Ropinprime 0.5 therapy", "overall motor function", "potential side effects", "Improved Motor Function", "individual patient needs", "uncomfortable sensations", "flexible dosing regimens", "Administration Instructions", "Restless Legs Syndrome Relief", "Swallow Ropinprime 0.5 tablets" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1893, "imageuri": "https://productimages.withfloats.com/actual/666be475844f2600246a0b63.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be475844f2600246a0b63.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:34:25.708Z", "updatedon": "2024-06-26T07:04:57.853Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-0-5-/1893", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 0.5 ", "category": "NEUROLOGY RANGE", "tags": [ "ropinprime 0.5 mg tablet 10", "ropinprime 0.5 mg tablet uses", "ropin 0.5 injection", "ropinirole warnings", "ropinirole side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ad72b56d62a1b8c8d620a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PRAMIXOLE 0.50 ", "description": "PRAMIXOLE 0.50 \nPramipexole (0.50mg)\nIntroduction:\n\nPRAMIXOLE 0.50 contains Pramipexole (0.50 mg), a dopamine agonist used to treat Parkinson’s disease and Restless Legs Syndrome (RLS). Pramipexole works by stimulating dopamine receptors in the brain, helping to improve movement control and alleviate symptoms associated with these conditions.\nKey Features and Benefits:\n\nParkinson’s Disease Management: Pramipexole is highly effective in managing symptoms of Parkinson’s disease, including tremors, stiffness, and slow movement, by enhancing the effects of dopamine.\nRestless Legs Syndrome Relief: It provides significant relief from the uncomfortable sensations and urge to move the legs, which are characteristic of Restless Legs Syndrome.\nImproved Motor Function: By stimulating dopamine receptors, Pramipexole improves motor function and coordination, enhancing the quality of life for patients with Parkinson’s disease.\nNeuroprotective Properties: Research suggests that Pramipexole may have neuroprotective effects, potentially slowing the progression of Parkinson’s disease.\nFlexible Dosing: The 0.50 mg dosage allows for precise adjustments based on individual needs and response to treatment.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of PRAMIXOLE 0.50 for Parkinson’s disease is 0.125 mg taken three times daily, gradually increased based on the patient's response to treatment. For Restless Legs Syndrome, the starting dose is usually 0.125 mg taken once daily, 2-3 hours before bedtime.\nMaintenance Dosage: The maintenance dose for Parkinson’s disease can range from 0.5 mg to 4.5 mg per day, divided into three doses. For RLS, the maintenance dose is typically 0.5 mg per day.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Pramipexole at the same time each day to maintain consistent medication levels in the bloodstream.\nMissed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not take a double dose to make up for a missed one.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/pramixole-0-50-133603", "price": 105.0, "discountamount": 31.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "day", "life", "food", "brain", "EMAIL", "Order", "water", "0.5 mg", "4.5 mg", "tablet", "tremors", "quality", "bedtime", "symptoms", "Benefits", "0.125 mg", "patients", "Research", "response", "Parkinson", "stiffness", "PRAMIXOLE", "same time", "next dose", "treatment", "conditions", "double dose", "three doses", "progression", "bloodstream", "information", "Pramipexole", "sterispharma", "coordination", "sterisonline", "Key Features", "Introduction", "CALL/WHATSAPP", "slow movement", "0.50 mg dosage", "Administration", "Initial Dosage", "Flexible Dosing", "dopamine agonist", "maintenance dose", "regular schedule", "individual needs", "movement control", "Disease Management", "significant relief", "Maintenance Dosage", "dopamine receptors", "precise adjustments", "typical starting dose", "neuroprotective effects", "Improved Motor Function", "uncomfortable sensations", "Neuroprotective Properties", "consistent medication levels", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1876, "imageuri": "https://productimages.withfloats.com/actual/666ad76c2d43284d727349be.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ad76c2d43284d727349be.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T11:25:31.913Z", "updatedon": "2024-06-26T07:45:10.553Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pramixole-0-50-/1876", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PRAMIXOLE 0.50 ", "category": "NEUROLOGY RANGE", "tags": [ "pramipexole 0.50 mg", "pramipexole 0.5 mg uses", "pramipexole long-term side effects", "pramipexole dosage", "pramipexole dosage for restless legs" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ad639162db0236048ad2f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PRAMIXOLE 0.25 ", "description": "PRAMIXOLE 0.25 \nPramipexole (0.25mg)\nIntroduction:\n\nPRAMIXOLE 0.25 contains Pramipexole (0.25 mg), a dopamine agonist used to treat Parkinson’s disease and Restless Legs Syndrome (RLS). Pramipexole works by stimulating dopamine receptors in the brain, which helps improve movement control and alleviate symptoms associated with these conditions.\nKey Features and Benefits:\n\nParkinson’s Disease Management: Pramipexole is highly effective in managing symptoms of Parkinson’s disease, including tremors, stiffness, and slow movement, by enhancing the effects of dopamine.\nRestless Legs Syndrome Relief: It provides significant relief from the uncomfortable sensations and urge to move the legs, which are characteristic of Restless Legs Syndrome.\nImproved Motor Function: By stimulating dopamine receptors, Pramipexole improves motor function and coordination, enhancing the quality of life for patients with Parkinson’s disease.\nNeuroprotective Properties: Research suggests that Pramipexole may have neuroprotective effects, potentially slowing the progression of Parkinson’s disease.\nFlexible Dosing: The 0.25 mg dosage allows for precise adjustments based on individual needs and response to treatment.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of PRAMIXOLE 0.25 for Parkinson’s disease is 0.25 mg taken once daily, gradually increased based on the patient's response to treatment. For Restless Legs Syndrome, the starting dose is usually 0.25 mg taken once daily, 2-3 hours before bedtime.\nMaintenance Dosage: The maintenance dose for Parkinson’s disease can range from 1.5 mg to 4.5 mg per day, divided into three doses. For RLS, the maintenance dose is typically 0.5 mg per day.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Pramipexole at the same time each day to maintain consistent medication levels in the bloodstream.\nMissed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not take a double dose to make up for a missed one.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/pramixole-0-25-133602", "price": 65.0, "discountamount": 19.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "day", "life", "food", "brain", "EMAIL", "Order", "water", "4.5 mg", "0.5 mg", "1.5 mg", "tablet", "tremors", "quality", "bedtime", "Benefits", "symptoms", "patients", "Research", "response", "Parkinson", "stiffness", "PRAMIXOLE", "same time", "next dose", "treatment", "conditions", "double dose", "three doses", "progression", "bloodstream", "information", "Pramipexole", "sterispharma", "coordination", "sterisonline", "Key Features", "Introduction", "CALL/WHATSAPP", "slow movement", "0.25 mg dosage", "Administration", "Initial Dosage", "Flexible Dosing", "dopamine agonist", "maintenance dose", "regular schedule", "individual needs", "movement control", "Disease Management", "significant relief", "Maintenance Dosage", "dopamine receptors", "precise adjustments", "typical starting dose", "neuroprotective effects", "Improved Motor Function", "uncomfortable sensations", "Neuroprotective Properties", "consistent medication levels", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1875, "imageuri": "https://productimages.withfloats.com/actual/666ad63d8c6c791fd3b5fbbe.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ad63d8c6c791fd3b5fbbe.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T11:21:29.729Z", "updatedon": "2024-06-26T07:46:39.439Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pramixole-0-25-/1875", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PRAMIXOLE 0.25 ", "category": "NEUROLOGY RANGE", "tags": [ "PRAMIXOLE 0.25", "", "Pramipexole (0.25mg)", "pramipexole 0.25 uses in hindi", "parkinson disease", "cost of pramipexole 0.25mg tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ad3a59b27ca0f04a6c9e6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PRAMIXOLE 0.125 ", "description": "PRAMIXOLE 0.125 \nPramipexole (0.125mg)\nIntroduction:\n\nPRAMIXOLE 0.125 contains Pramipexole (0.125 mg), a dopamine agonist used to treat Parkinson’s disease and Restless Legs Syndrome (RLS). Pramipexole works by stimulating dopamine receptors in the brain, which helps to improve movement control and alleviate symptoms associated with these conditions.\nKey Features and Benefits:\n\nParkinson’s Disease Management: Pramipexole is highly effective in managing symptoms of Parkinson’s disease, including tremors, stiffness, and slow movement, by enhancing the effects of dopamine.\nRestless Legs Syndrome Relief: It provides significant relief from the uncomfortable sensations and urge to move the legs, which are characteristic of Restless Legs Syndrome.\nImproved Motor Function: By stimulating dopamine receptors, Pramipexole improves motor function and coordination, enhancing the quality of life for patients with Parkinson’s disease.\nNeuroprotective Properties: Research suggests that Pramipexole may have neuroprotective effects, potentially slowing the progression of Parkinson’s disease.\nFlexible Dosing: The 0.125 mg dosage allows for precise adjustments based on individual needs and response to treatment.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of PRAMIXOLE 0.125 for Parkinson’s disease is 0.125 mg taken once daily, gradually increased based on the patient's response to treatment. For Restless Legs Syndrome, the starting dose is usually 0.125 mg taken once daily, 2-3 hours before bedtime.\nMaintenance Dosage: The maintenance dose for Parkinson’s disease can range from 0.5 mg to 1.5 mg per day, divided into three doses. For RLS, the maintenance dose is typically 0.5 mg per day.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Pramipexole at the same time each day to maintain consistent medication levels in the bloodstream.\nMissed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not take a double dose to make up for a missed one.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/pramixole-0-125-133601", "price": 54.0, "discountamount": 16.2, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "RLS", "life", "food", "brain", "EMAIL", "Order", "water", "tablet", "0.5 mg", "1.5 mg", "quality", "tremors", "bedtime", "Research", "patients", "Benefits", "symptoms", "response", "same time", "Parkinson", "PRAMIXOLE", "next dose", "treatment", "stiffness", "conditions", "double dose", "three doses", "progression", "bloodstream", "information", "Pramipexole", "coordination", "sterispharma", "sterisonline", "Key Features", "Introduction", "CALL/WHATSAPP", "slow movement", "Administration", "Initial Dosage", "Flexible Dosing", "0.125 mg dosage", "regular schedule", "individual needs", "dopamine agonist", "maintenance dose", "movement control", "dopamine receptors", "Disease Management", "Maintenance Dosage", "significant relief", "precise adjustments", "typical starting dose", "Improved Motor Function", "neuroprotective effects", "uncomfortable sensations", "Neuroprotective Properties", "consistent medication levels", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1874, "imageuri": "https://productimages.withfloats.com/actual/666ad3aa844f260024694529.png", "tileimageuri": "https://productimages.withfloats.com/tile/666ad3aa844f260024694529.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T11:10:29.979Z", "updatedon": "2024-06-29T12:35:16.824Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pramixole-0-125-/1874", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PRAMIXOLE 0.125 ", "category": "NEUROLOGY RANGE", "tags": [ "side effects of pramipexole 0.125mg", "pramipexole 0.125 mg dosage", "pramipexole restless legs dose", "side effects of pramipex 0.25" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }